Financhill
Back

Vir Biotechnology Quote, Financials, Valuation and Earnings

Sell
43

VIR
Vir Biotechnology

Last Price:
9.72
Seasonality Move:
13.28%

7 Day Trial

ALL ACCESS PASS

$ 7

Vir Biotechnology Price Quote

$9.72
-0.01 (-2.11%)
(Updated: May 18, 2024 at 5:55 AM ET)

Vir Biotechnology Key Stats

Sell
43
Vir Biotechnology (VIR) is a Sell

Day range:
$9.61 - $10.07
52-week range:
$7.61 - $27.48
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
29.77
P/B ratio:
0.86%

Volume:
644.2K
Avg. volume:
891.7K
1-year change:
-61.1%
Market cap:
$1.3B
Revenue:
$39.5M
EPS:
$-4.01

How Much Does Vir Biotechnology Make?

Is Vir Biotechnology Growing As A Company?

  • What Is Vir Biotechnology's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.1%
  • What Is Vir Biotechnology's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Vir Biotechnology Stock Price Performance

  • Did Vir Biotechnology Stock Go Up Last Month?
    Vir Biotechnology share price went up by 17.94% last month
  • Did VIR's Share Price Rise Over The Last Year?
    VIR share price fell by -61.1% over the past 1 year

What Is Vir Biotechnology 52-Week High & Low?

Vir Biotechnology Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Vir Biotechnology?

  • How Much Debt Does Vir Biotechnology Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Vir Biotechnology Have?
    Cash and short term investments quarterly total is $1.1B
  • What Is Vir Biotechnology’s Book Value Per Share?
    Book value per share is 11.39

Is Vir Biotechnology Cash Flow Positive?

Data Unavailable

Vir Biotechnology Return On Invested Capital

  • Is Management Doing A Good Job?
    VIR return on invested capital is -31.39%
  • What Is Vir Biotechnology Return On Assets?
    ROA measures how assets are converting to revenues and is -25.28%
  • What Is VIR Return On Equity?
    ROE is a measure of profitability and is -31.39%

Vir Biotechnology Earnings Date & Stock Price

Vir Biotechnology Competitors

  • Who Are Vir Biotechnology's Competitors?
    Below is a list of companies who compete with Vir Biotechnology or are related in some way:
    • iBio Inc (IBIO)
    • SeaStar Medical Holding Corp (ICU)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Vertex Pharmaceuticals Inc (VRTX)

Vir Biotechnology Dividend Yield

Data Unavailable

Vir Biotechnology Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 54.27%
Revenue: 9.62% 381.34%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 29.75
Upside from Last Price: 205.76%

Major Shareholders

  • How many VIR shares are owned by institutional investors?
    134M VIR shares are owned by institutional investors
  • How many VIR shares are owned by insiders?
    4.7M VIR shares are owned by insiders